Bupropion Hydrochloride Tablet, Film Coated, Extended Release
Product Images NDC 71205-550

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Bupropion Hydrochloride (NDC 71205-550). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205-550-60 (Bupropion 150mg 30tab)

71205-550-60 (Bupropion 150mg 30tab)
This is a description of medication containing Bupropion HCI 150mg (Twice-A-Day), specifically #60 E.R. Tablets. The tablets are purple, blackberry-flavored, round, biconvex and film-coated. They are to be dispensed along with a medication guide to each patient. The medication should be kept out of reach of children and not combined with ZYBAN® or any other medications that contain bupropion hydrochloride. The manufacturer is ScieGen Phamaceuticals, Inc., located in Hauppauge, NY. The medication should be stored at 20°-25°C (68°-77°F). The lot number is 00000 and the expiration date is 00/00/00.*
FDA Label Image

Chemical Structure (Bupropion Hydrochloride Sr 1)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.